Basal limbic system alteration in major depression: A hypothesis supported by transcranial sonography and MRI findings

International Journal of Neuropsychopharmacology

Volumn 4, Issue 1, 2001, Pages 21-31

  Becker, Georg ^a,c   Berg, Daniela ^a   Lesch, Klaus Peter ^c   Becker, Thomas ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Affective disorders; Limbic system; Major depression; Parkinson's disease; Transcranial ultrasound

Indexed keywords

BRAIN INJURY; BRAIN STEM; DEGENERATIVE DISEASE; DEPRESSION; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; LIMBIC SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL PROCESSING; STRUCTURE ANALYSIS;

BRAIN STEM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LIMBIC SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; PARKINSON DISEASE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 0035040185     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145701002164     Document Type: Review

References (98)

1. Fewer pigmented locus coeruleus neurons in suicide victims: Preliminary results
2. CSF monoamine metabolites in melancholia
3. Reduced G protein functions and immunoreactive levels in mononuclear leukocytes of patients with depression
4. Biology of depression and mania
5. Postmortem analysis of noradrenergic and serotonergic brainstem systems in mood disorders
6. Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology
7. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F18
8. Reduction of prefrontal cortex glucose metabolism common to three types of depression
9. Pathological findings in neuropsychiatric disorders
10. Reduced echogenicity of brainstem raphe specific to unipolar depression: A transcranial color-coded real-time sonography study
11. Increased tissue copper and manganese content of the lentiform nucleus in primary adult-onset dystonia
12. Examination techniques
13. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography
14. Echogenicity of the brainstem raphe in patients with major depression
15. Parkinson's disease and depression, evidence for an alteration of the basal limbic system detected by transcranial sonography
16. The anatomy of melancholia-focal abnormalities of cerebral blood flow in major depression
17. Changes in regional cerebral blood flow on recovery from depression
18. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound
19. Depression in Parkinson's disease: Brainstem midline alteration on transcranial sonography and magnetic resonance imaging
20. Multiple sclerosis and depression - Pathogenetic differences compared with depression in neurodegenerative disorders
21. Serotonin 5-HT2 receptor imaging in major depression: Focal changes in orbito-insular cortex
22. Transcranial color-coded real-time sonography in adults
23. Die bedeutung der serotonergen raphe-kortex-projektion für die beeinflussung der adrenergen neurotransmission durch antidepressiva
24. 18F]2-deoxyglucose in affective illness
25. Quantification of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression
26. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study
27. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders
28. Genetics of bipolar disorder
29. PET imaging of serotonin 1A receptor binding in depression
30. A molecular and cellular theory of depression
31. Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: A study with Tc-99m-HMPAO SPECT
32. The neurobiological substrates of depression in Parkinson's disease
33. Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides
34. Histological and enzymatic studies of the mesolimbic and mesostriatal serotonergic pathways
35. The meso-corticoprefrontal dopaminergic neurons
36. Cerebrospinal fluid amine metabolites in affective illness. The probenecid technique
37. Variability in the serotonin transporter gene and increased risk for major depression with melancholia
38. Functional topography of brain serotonergic pathways in rat
39. Subcortical limbic system projections to the caudal brainstem and spinal cord
40. A magnetic resonance imaging study of putamen nuclei in major depression
41. The pedunculopontine tegmental nucleus, where the striatum meets the reticular formation
42. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique
43. Neuroanatomical studies of major affective disorders. A review and suggestions for further research
44. The role of noradrenergic locus coeruleus neurons and neighboring cholinergic neurons of the pontomesencephalic tegmentum in sleep-wake states
45. Descending noradrenergic influences on pain
46. Predictors of drug response in depression
47. Clinical characteristics of major depression that predict risk of depression in relatives
48. Urinary dopamine sulfate: Regulations and significance in neurological disorders
49. Long-term stress degenerates, but imipramine regenerates, noradrenergic axons in the rat cerebral cortex
50. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression
51. Depression and Parkinson's disease: Possible role of serotonergic mechanisms
52. Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations
53. Surgical anatomy of the brainstem
54. In vivo evidence for the involvement of dopamine-D2 receptors in striatum and anterior cingulate gyrus in major depression
55. The role of noradrenalin in depression: A review
56. Genetically driven variation in serotonin uptake: Is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders
57. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography
58. Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders
59. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior
60. Left prefrontal glucose hypometabolism in the depressed state: A confirmation
61. Paralimbic hypoperfusion in unipolar depression
62. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease
63. The relationship of serotonin to depression in Parkinson's disease
64. Clinical and biochemical features of depression in Parkinson's diesase
65. Depression and anxiety in Parkinson's disease: Possible effect of genetic variation in the serotonin transporter
66. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression
67. Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: A phosphorous-31 magnetic resonance spectroscopy study
68. The serotonin transporter in Alzheimer's and Parkinson's disease
69. Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography
70. Polymorphism in serotonin transporter gene associated with susceptibility to major depression
71. Positive association between the GABRA5 gene and unipolar recurrent major depression
72. Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients
73. The neuropathologic basis of different clinical subgroups of Parkinson's disease
74. The neuroanatomical basis of anxiety
75. Comparison of B-mode imaging and tissue harmonic imaging
76. Basal ganglia choline levels in depression and response to fluoxetine treatment: An in vivo proton magnetic resonance spectroscopy study
77. Depression in Parkinson's disease. A positron emission study
78. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia
79. Regional cerebral blood flow in mood disorders. IV. Comparison of mania and depression
80. Coexisting dementia and depression in Parkinson's disease
81. Densities of 12-imidazoline receptors, alpha 2-adrenoceptors and monoamine oxidase B in brains of suicide victims
82. Caffeine antinociception in the rat hot-plate and formalin tests and locomotor stimulation: Involvement of noradrenergic mechanisms
83. Neuropharmacology of affective disorders
84. Posterior fossa abnormalities in major depression: A controlled magnetic resonance imaging study
85. cAMP-dependent protein kinase activity in major depression
86. Altered activity of the locus coeruleus in animal models of depression
87. Imaging of the serotonergic system: Interactions of neuroanatomical and functional abnormalities of depression
88. Kindling of the mesolimbic dopamine system: Animal model of psychosis
89. Monoaminergic mechanisms in affective disorders
90. Association of ventral tegmental area histopathology with adult dementia
91. Central monoamine deficiency in depressions, causative or secondary phenomenon?
92. Cerebral monoamines and depression. An investigation with the probenecid technique
93. Depression and anxiety: Role of the locus coeruleus and corticotropin-releasing factor
94. The effects of ventral tegmental administration of GABAA, GABAB and NMDA receptor agonists on medial forebrain bundle self-stimulation
95. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment, a positron emission tomography study with fluorine-18-labeled setoperone
96. Decreased raphe unit activity in a rat model of endogenous depression